Information about major medicine shortages

Key information about the shortage for patients, carers and health care professionals

Find out about the discontinuation of Ryzodeg 70/30 FlexTouch insulin prefilled pens.

Check this page for key information and updates on the Trulicity shortage.

Check this page for key information and updates on the Ozempic shortage.

Key information and updates about the shortage of methylphenidate hydrochloride products.

Information about the shortages of HRT products for patients and healthcare professionals

Find out about the discontinuation of Protaphane InnoLet insulin cartridges and the substitute product available.

Information about the shortages of IV fluid products

Key information and updates about the shortage of metformin immediate-release tablets.

Information about the supply of oral opioid medicines that are in shortage and products that have been discontinued

Pharmaceutical company Novo Nordisk has advised us that it will gradually discontinue some of its earlier generation insulin products between late 2024 and late 2026. We recognise the vital role of insulin for people with diabetes in Australia and will work to minimise the impact of these discontinuations by providing early advice that includes alternative options.